OOIR: Observatory of International Research

Papers

(The H4-Index of Radiotherapy and Oncology is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Call For Papers: Radiotherapy & Oncology and The Lancet Oncology collaboration	209
44 Ultrahypofractionated Versus Moderately Hypofractionated and Conventionally Fractionated Pelvic Radiotherapy for Prostate Cancer: Outcomes from 3 Prospective Clinical Trials	124
529 Current standard of care treatment in non-metastatic cervix cancer	124
80 Stereotactic Body Radiation Therapy for Intrahepatic Graft Recurrence of Hepatocellular Carcinoma After Liver Transplantation	108
292 Correlation of cf DNA with response in head & neck cancer treated with definitive chemoradiotherapy	107
122 Effect of Different Treatment Planning Optimizers on Stereotactic Ablation Radiotherapy (SABR) Volumetric Modulated ARC Therapy (VMAT) Plans	97
23 Stereotactic Body Versus Conventional Fractionation External Beam Radiotherapy (EBRT) Boost for High-Risk Prostate Cancer (HR-PC); Early Results of PBS: A Phase II Randomized Trial (NCT03380806)	94
31 Program Director Perspectives on the Implementation and Experiences of the Competence By Design Curriculum in Canadian Radiation Oncology Training Programs	92
525 Proton and carbon therapy: recent technological advances	90
33 An investigator-initiated clinical study using SBRT as “in situ vaccination”:‘R-ISV-FOLactis’trial	89
45 Stereotactic radiosurgery for tremor: a center experience.	87
54 Scattered Radiation to the Testis and Testosterone Secretion in Prostate Cancer Treated with Radiotherapy Alone	80
207 ctDNA-based WES enhances actionable alterations detection in locally advanced head and neck cancer	78
157 Adaptive radiation therapy	77
480 Addressing the education and training needs of RTT in particle radiation therapy	73
937: Prediction of the dose-averaged proton linear energy transfer using convolutional neural networks	71
2076: RapidBrachyIVBT: A dosimetry software for personalized image-guided intravascular brachytherapy	71
3007: SABR prior to liver transplantation in HCC patients: a 10 years’ experience	69
3050: Impact of a philanthropic online course about cervical cancer on the learning outcome	68
158: Validation of intrafraction prostate drift corrections on a 1.5T MR-linac using cine-MRI	65
2030: Impact & usability of virtual reality on emotional wellbeing of sarcoma patients:VR-SARC study	63
1086: Urethra-sparing single-dose ablative prostate radiotherapy with real-time motion management	63
3429: Modulating innate immunity by DNA damage response inhibition	62
1583: Phantom-based optimization of virtual monoenergetic image reconstruction in dual-energy CT	62
1232: Modern era radical radiotherapy toxicity: a preliminary CONCORDE analysis of the calibration arm	61

749: Reinforcement learning for accelerated automatic treatment planning optimization	60
1062: Micro-dissected tumour tissues-on-chip; a tool for translational radiation oncology	59
204: PET-CT DenseNet outperforms advanced DL models for outcome prediction of oropharyngeal cancer	58
1635: In vivo dosimetry - keeping my finger on the pulse	55
2975: UHRT in PCa: a clinical and toxicity impact analysis from real world experience.	55
2486: Impact of patient specific deep learning OAR segmentation on accumulated online adapted MRgRT dose	54
1861: Performance of a heart substructures autocontouring tool after clinical implementation	52
687: Hearing loss after cranial radiation in children: a dosimetry study from the French registry PediaRT	49
1933: High-resolution Diode array vs film for QA of trigeminal neuralgia treatments with Cyberknife	48
3201: Dosimetric properties of flexible 3D-printed boluses	47
941: Should Varian HyperArc make us re-think how we use conventional linacs for SRS?	46
1962: Study protocol B-REST: respiratory und relaxation training in adjuvant radiotherapy of breast cancer	46
2607: Carbon footprint reduction with the adoption of hypofractionation in a public health facility	46
2311: Treatment plan robustness in IMPT for esophageal cancer: every millimeter counts.	45
1487: Radiotherapy access in the Asia-Pacific: Are we making progress for low- & middle-income countries?	44
1432: Comparative study of various homogeneity indices in SIB-VMAT planning for head and neck tumors.	44
760: Dependence on the calibration field in treatment verifications using the 1600SRS liquid array	43
285: Metal artifact in MR-based synthetic CT for intracranial radiotherapy: impact on dosimetry and setup	43
1586: Dose perturbation due to surgical clips and titanium mesh in proton therapy	43
1977: PSMA-PET and PCa: an ancillary RADIOSA study beyond a numerical definition of oligometastatic state	43